| USD millions | FY2025 | TTM |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Cost of revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Research & development | 0.0 | — |
| Selling, general & administrative | 16.1 | — |
| Selling & marketing | 0.0 | — |
| Operating expenses | 16.1 | — |
| Operating income | 0.0 | (0.9) |
| Interest expense | (0.2) | 0.0 |
| Interest income | 0.0 | 4.5 |
| Other income / expense | 0.0 | — |
| Pre-tax income | (15.7) | 3.7 |
| Income tax | 0.0 | 0.0 |
| Net income | (15.7) | (3.2) |
| Discontinued operations | 0.0 | — |
| Other net income adjustments | 0.0 | — |
| EPS, basic (per share) | (2.13) | (0.46) |
| EPS, diluted (per share) | (2.13) | (0.46) |
| EBITDA | 0.0 | (0.2) |
| Depreciation & amortization | 0.0 | — |
| Weighted average shares (shares) | 7,385,168 | — |
| Weighted average diluted shares (shares) | 7,385,168 | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.